Clinical outcomes in 2003-33 and 2006-66 trials. Overall survival (OS; A) and event-free survival (EFS; B) from initiation of therapy, as well as timing of onset of complete response (CR) from treatment start (C). Complete response duration (CRD) was measured from onset of CR (D).